Hinge Health (HNGE) Research & Development (2024 - 2026)

Hinge Health has disclosed Research & Development across 3 years of filings, most recently posting $81.4 million for Q2 2026.

• In Q2 2026, Research & Development fell 70.92% year-over-year to $81.4 million; the TTM figure through Jun 2026 stood at $246.5 million (down 39.39% YoY), while the FY2025 annual figure was $368.1 million, up 120.36% from the prior year.
• Research & Development came in at $81.4 million for Q2 2026 at Hinge Health, up from $68.8 million in the prior quarter.
• In the past five years, Research & Development ranged from a high of $280.0 million in Q2 2025 to a low of $32.8 million in Q4 2025.
• Average Research & Development over 3 years is $77.6 million, with a median of $46.7 million recorded in 2025.
• Year-over-year, Research & Development surged 523.61% in 2025 and plunged 70.92% in 2026.
• Over 3 years, Research & Development stood at $35.5 million in 2024, then slipped by 7.6% to $32.8 million in 2025, then soared by 148.54% to $81.4 million in 2026.
• Per Business Quant data, the three most recent Research & Development figures were $81.4 million in Q2 2026, $68.8 million in Q1 2026, and $32.8 million in Q4 2025.